Xintela AB (publ) (STO:XINT)
Sweden · Delayed Price · Currency is SEK 0.1550
-0.0010 (-0.64%)
Nov 2, 2026, 5:21 PM CET
Xintela AB Market Cap
Xintela AB has a market cap or net worth of 133.5 million as of November 2, 2026. It is the 39,513th most valuable company in the world and the 559th biggest in Sweden. Its market cap has decreased by 54.56% in one year.
Market Cap
133.50M
Enterprise Value
154.67M
Revenue
3.03M
Global Rank
Country Rank
#559 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since March 22, 2016, Xintela AB's market cap has increased from 103.68M to 133.50M, an increase of 28.76%. That is a compound annual growth rate of 2.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 133.50M | -32.81% |
| Dec 30, 2025 | 198.68M | 5.85% |
| Dec 30, 2024 | 187.69M | 26.87% |
| Dec 29, 2023 | 147.94M | -1.74% |
| Dec 30, 2022 | 150.56M | -26.24% |
| Dec 30, 2021 | 204.12M | 2.23% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Elicera Therapeutics AB | 177.19M |
| Simris Group AB (PUBL) | 163.32M |
| Diamyd Medical AB | 154.36M |
| Abera Bioscience AB | 140.62M |
| Biovica International AB | 139.73M |
| Initiator Pharma | 133.14M |
| Alzinova AB | 112.04M |
| Active Biotech AB | 105.31M |